• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Probable ATP-dependent RNA helicase DDX60 (DDX60), Truncated

ACP01326

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01326 Target NameDDX60
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range772-939aaMol Weight26.5 kDa
Protein LengthPartialPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8IY21
Background Information
  • Uniprot Id

    Q8IY21

  • Target Species

    Human

  • Target Name

    DDX60

  • Target Full Name

    Probable ATP-dependent RNA helicase DDX60

  • Target Function

    Positively regulates DDX58/RIG-I- and IFIH1/MDA5-dependent type I interferon and interferon inducible gene expression in response to viral infection. Binds ssRNA, dsRNA and dsDNA and can promote the binding of DDX58/RIG-I to dsRNA. Exhibits antiviral activity against hepatitis C virus and vesicular stomatitis virus (VSV).

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    Helicase family

  • Target Tissue Specificity

    Brain, lymph node, prostate, stomach, thyroid, tongue, trachea, uterus, skeletal muscle, spleen, kidney, liver and small intestine.

  • Target Research Area

    Others

  • Target Synonyms

    DDX60; DDX60_HUMAN; DEAD (Asp-Glu-Ala-Asp) box polypeptide 60; DEAD box protein 60; Probable ATP-dependent RNA helicase DDX60

Inquire Recombinant Human Probable ATP-dependent RNA helicase DDX60 (DDX60), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification